Abstract
Five to 10% of the general population suffers from symptoms of an anxiety disorder. Social phobias, while less common than panic disorder, agoraphobia or simple phobias, are just as debilitating. Patients present with somatic, behavioural, mood and cognitive disturbances, of which unrecognized social isolation, depression, loss of employment, and drug and alcohol abuse can be the result. A symptomatic approach can be implemented through the use of education, insight, support, behaviour therapy, cognitive therapy, and pharmacological intervention.
Keywords: social phobia, behaviour therapy, beta-blocker
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agras S., Sylvester D., Oliveau D. The epidemiology of common fears and phobia. Compr Psychiatry. 1969 Mar;10(2):151–156. doi: 10.1016/0010-440x(69)90022-4. [DOI] [PubMed] [Google Scholar]
- Amies P. L., Gelder M. G., Shaw P. M. Social phobia: a comparative clinical study. Br J Psychiatry. 1983 Feb;142:174–179. doi: 10.1192/bjp.142.2.174. [DOI] [PubMed] [Google Scholar]
- Brantigan C. O., Brantigan T. A., Joseph N. Effect of beta blockade and beta stimulation on stage fright. Am J Med. 1982 Jan;72(1):88–94. doi: 10.1016/0002-9343(82)90592-7. [DOI] [PubMed] [Google Scholar]
- Falloon I. R., Lloyd G. G., Harpin R. E. The treatment of social phobia. Real-life rehearsal with nonprofessional therapists. J Nerv Ment Dis. 1981 Mar;169(3):180–184. doi: 10.1097/00005053-198103000-00005. [DOI] [PubMed] [Google Scholar]
- Gorman J. M., Gorman L. K. Drug treatment of social phobia. J Affect Disord. 1987 Sep-Oct;13(2):183–192. doi: 10.1016/0165-0327(87)90022-x. [DOI] [PubMed] [Google Scholar]
- Gorman J. M., Liebowitz M. R., Fyer A. J., Campeas R., Klein D. F. Treatment of social phobia with atenolol. J Clin Psychopharmacol. 1985 Oct;5(5):298–301. doi: 10.1097/00004714-198510000-00009. [DOI] [PubMed] [Google Scholar]
- Gottschalk L. A., Stone W. N., Gleser G. C. Peripheral versus central mechanisms accounting for antianxiety effects of propranolol. Psychosom Med. 1974 Jan-Feb;36(1):47–56. doi: 10.1097/00006842-197401000-00004. [DOI] [PubMed] [Google Scholar]
- Hartley L. R., Ungapen S., Davie I., Spencer D. J. The effect of beta adrenergic blocking drugs on speakers' performance and memory. Br J Psychiatry. 1983 May;142:512–517. doi: 10.1192/bjp.142.5.512. [DOI] [PubMed] [Google Scholar]
- Hayes B. J., Marshall W. L. Generalization of treatment effects in training public speakers. Behav Res Ther. 1984;22(5):519–533. doi: 10.1016/0005-7967(84)90055-x. [DOI] [PubMed] [Google Scholar]
- James I. M., Burgoyne W., Savage I. T. Effect of pindolol on stress-related disturbances of musical performance: preliminary communication. J R Soc Med. 1983 Mar;76(3):194–196. doi: 10.1177/014107688307600308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liebowitz M. R., Gorman J., Fyer A., Campeas R., Levin A., Davies S., Klein D. F. Psychopharmacological treatment of social phobia. Psychopharmacol Bull. 1985;21(3):610–614. [PubMed] [Google Scholar]
- Marks I. M. The classification of phobic disorders. Br J Psychiatry. 1970 Apr;116(533):377–386. doi: 10.1192/bjp.116.533.377. [DOI] [PubMed] [Google Scholar]
- Myers J. K., Weissman M. M., Tischler G. L., Holzer C. E., 3rd, Leaf P. J., Orvaschel H., Anthony J. C., Boyd J. H., Burke J. D., Jr, Kramer M. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry. 1984 Oct;41(10):959–967. doi: 10.1001/archpsyc.1984.01790210041006. [DOI] [PubMed] [Google Scholar]
- Solyom C., Solyom L., LaPierre Y., Pecknold J., Morton L. Phenelzine and exposure in the treatment of phobias. Biol Psychiatry. 1981 Mar;16(3):239–247. [PubMed] [Google Scholar]
- Tyrer P., Steinberg D. Symptomatic treatment of agoraphobia and social phobias: a follow-up study. Br J Psychiatry. 1975 Aug;127:163–168. doi: 10.1192/bjp.127.2.163. [DOI] [PubMed] [Google Scholar]